REGULATED PRESS RELEASE published on 05/28/2024 at 18:01, 2 years ago bioMérieux obtient l'agrément 510(k) de la FDA pour le test innovant VIDAS® TBI (GFAP, UCH-L1), visant à améliorer l’évaluation des patients victimes d'un traumatisme crânien léger bioMérieux obtient l'agrément 510(k) de la FDA pour le test VIDAS® TBI (GFAP, UCH-L1) améliorant l'évaluation des traumatismes crâniens légers FDA BioMérieux Agrément 510(k) VIDAS TBI Traumatisme Crânien Léger
BRIEF published on 05/23/2024 at 13:07, 2 years ago Le Malawi s'attaque à l'antibiorésistance grâce à une collaboration multisectorielle BioMérieux Antibiorésistance Santé Publique Malawi Pfizer
BRIEF published on 05/23/2024 at 13:07, 2 years ago Malawi Ministry of Health, bioMérieux, and Pfizer Form Country's First Multisectoral Collaboration to Address Antimicrobial Resistance BioMérieux Antimicrobial Resistance Public Health Pfizer Malawi Health
REGULATED PRESS RELEASE published on 05/23/2024 at 13:02, 2 years ago Le Ministère de la Santé du Malawi, bioMérieux et Pfizer créent la première collaboration multisectorielle dans ce pays pour lutter contre l'antibiorésistance Le Ministère de la Santé du Malawi, bioMérieux et Pfizer lancent une collaboration contre l'antibiorésistance avec des initiatives multisectorielles innovantes. Objectif : renforcer l'action publique et l'usage approprié des antibiotiques BioMérieux Antibiorésistance Malawi Pfizer Ministère De La Santé
REGULATED PRESS RELEASE published on 05/23/2024 at 13:02, 2 years ago Malawi Ministry of Health, bioMérieux, and Pfizer Form Country’s First Multisectoral Collaboration to Help Address Antimicrobial Resistance Malawi Ministry of Health, bioMérieux, and Pfizer collaborate to address antimicrobial resistance in Malawi through infection prevention, control, diagnostics, and surveillance. The initiative aims to combat AMR, a global health threat BioMérieux Antimicrobial Resistance Collaboration Pfizer Malawi Ministry Of Health
BRIEF published on 05/06/2024 at 17:23, 2 years 1 month ago Mise à jour financière de bioMérieux : Aperçu du capital social et des droits de vote en avril 2024 Droits De Vote Capital Social BioMérieux Actions Diagnostic In Vitro
BRIEF published on 05/06/2024 at 17:23, 2 years 1 month ago BioMérieux financial update: Overview of share capital and voting rights in April 2024 Share Capital Voting Rights BioMérieux Actions In Vitro Diagnostics
REGULATED PRESS RELEASE published on 05/06/2024 at 17:18, 2 years 1 month ago Avril 2024 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant Communiqué de presse mensuel de bioMérieux concernant le nombre total de droits de vote et d'actions, conformément aux réglementations financières en vigueur Autorité Des Marchés Financiers BioMérieux Nombre De Droits De Vote Règlement Général Informations Mensuelles
BRIEF published on 04/09/2024 at 07:20, 2 years 2 months ago BioMérieux Outlines Ambitious Five-Year Strategic Growth Plan Corporate Social Responsibility BioMérieux In Vitro Diagnostics Sustainable Growth GO•28 Strategic Plan
BRIEF published on 04/09/2024 at 07:20, 2 years 2 months ago BioMérieux dévoile GO•28, son plan stratégique quinquennal BioMérieux Diagnostic In Vitro Croissance Organique RSE GO•28
Published on 06/20/2026 at 01:00, 22 hours 29 minutes ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 23 hours 29 minutes ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 1 day 18 hours ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 1 day 22 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 1 day 22 hours ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/20/2026 at 21:25, 2 hours 4 minutes ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 17 hours 29 minutes ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 1 day 3 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 1 day 3 hours ago 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:01, 1 day 4 hours ago Fuller, Smith & Turner PLC: Publication of the Annual Report and Accounts for the 52 weeks ending 28 March 2026 and Notice of 2026 Annual General Meeting
Published on 06/19/2026 at 19:33, 1 day 3 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 1 day 3 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 1 day 4 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 1 day 4 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026